Release of GM‐CSF and G‐CSF by human arterial and venous smooth muscle cells: differential regulation by COX‐2
Open Access
- 1 March 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 129 (5) , 835-838
- https://doi.org/10.1038/sj.bjp.0703151
Abstract
In addition to their traditional contractile function, vascular smooth muscle cells can be stimulated under inflammatory conditions to release a range of potent biological mediators. Indeed, we and others have shown that human vascular smooth muscle release the colony stimulating factors (CSF) granulocyte macrophage‐CSF (GM‐CSF) and granulocyte‐CSF (G‐CSF) as well as large amounts of prostaglandins following the induction of cyclo‐oxygenase‐2 (COX‐2), when stimulated with cytokines. Here we demonstrate, for the first time, that co‐induced COX‐2 activity simultaneously suppresses GM‐CSF release and potentiates G‐CSF release by human vascular cells. Moreover, the differential regulation of GM‐CSF and G‐CSF release by COX‐2 was mimicked by the prostacyclin (PGI2) mimetic, cicaprost. These observations suggest that PGI2, released following the induction of COX‐2, differentially regulates the release of GM‐CSF (suppresses) and G‐CSF (potentiates) from human vascular cells. British Journal of Pharmacology (2000) 129, 835–838; doi:10.1038/sj.bjp.0703151Keywords
This publication has 20 references indexed in Scilit:
- Cyclooxygenase-2 Regulates Granulocyte-Macrophage Colony–Stimulating Factor, but Not Interleukin-8, Production by Human Vascular CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapyBritish Journal of Pharmacology, 1999
- Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysisProceedings of the National Academy of Sciences, 1999
- Differential Induction of Cyclooxygenase-2 in Human Arterial and Venous Smooth MuscleArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Prostacyclin Modulates Granulocyte/Macrophage Colony-Stimulating Factor Release By Human Blood Mononuclear CellsPulmonary Pharmacology, 1996
- Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.Proceedings of the National Academy of Sciences, 1993
- Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products.1992
- Long term cultures of human monocytes in vitro impact of GM-CSF on survival and differentiationJournal of Immunological Methods, 1991
- Examination of survival, proliferation and cell surface antigen expression of human monocytes exposed to macrophage colony‐stimulating factor (M‐CSF)The International Journal of Cell Cloning, 1990
- Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.Journal of Clinical Investigation, 1986